P&G Likely To Keep Prilosec OTC, Vicks In Portfolio Shuffle – Analysts

P&G’s plan to sell half of its brands triggered speculation about what the firm will keep and what it will sell. A Bernstein analyst predicts the firm will part with many oral care products and dietary supplements, but will keep consumer health brands including Prilosec OTC, Vicks and Crest.

Firms worldwide interested in growing their consumer health care businesses with established oral care or dietary supplement lines could benefit from Procter & Gamble Co.’s plan to divest or discontinue about half of its brands.

Braun/Oral-B electric toothbrushes, Glide dental floss, Blend-a-Dent denture adhesive and a bevy of toothpaste lines sold worldwide, including Parogencyle, Fluocaril and Zooth could be among the oral care brands on the

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Asia